Picture of Exelixis logo

EXEL — Exelixis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Exelixis Says Cabometyx Reduces Risk Of Progression Or Death By 74% In Non-Functional Net, 60% In Functional Net

BRIEF-Exelixis Says Cabometyx Reduces Risk Of Progression Or Death By 74% In Non-Functional Net, 60% In Functional Net

- Exelixis Inc EXEL.O:

  • EXELIXIS - CABOMETYX REDUCES RISK OF PROGRESSION OR DEATH BY 74% IN NON-FUNCTIONAL NET, 60% IN FUNCTIONAL NET

Source text: ID:nBw6fbBPFa

Further company coverage: EXEL.O


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Exelixis

See all news